)
Visual22 Oct 2025
Epiroc's cash spent on M&A
Aytu Biopharma (AYTU) investor relations material
Aytu Biopharma Planet MicroCap Showcase: TORONTO 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Planet MicroCap Showcase: TORONTO 2025 summary22 Oct, 2025
Strategic transformation and business focus
Shifted to a pure-play CNS specialty pharma, divesting non-core assets and consumer health business since 2022.
Outsourced manufacturing, reorganized headcount, and improved adjusted EBITDA by $35 million.
Paid off and refinanced term loan, cleaned up balance sheet, and now sits on $31 million cash.
Core ADHD products generate $58 million of $66 million total revenue, with stable gross margins around 69%.
Out-licensed ADHD products in Israel and Canada, with future revenue expected.
Product portfolio and market positioning
ADHD portfolio includes Adzenys, Cotempla, and recently launched Metadate CD, with strong prescription growth due to U.S. Adderall shortages.
RxConnect patient access program ensures affordable prescriptions and high refill rates, with 85% of scripts through 1,000+ contracted pharmacies.
Sales force of 40 reps targets psychiatrists and GPs, with 60% overlap for new MDD product Exxua.
ADHD market share is about 0.6%, but business is stable and cash flow neutral.
Exxua (Gepirone) launch and opportunity
Licensed Exxua for MDD, approved in September 2023, launching December 2024, with patent protection through 2030 and plans for extension.
Exxua targets a $22 billion MDD market, with 340 million annual prescriptions, and is positioned as a third- or fourth-line therapy.
Key differentiator: no sexual dysfunction or weight change side effects, unlike SSRIs/SNRIs.
Clinical trials showed efficacy by week three, with transient dizziness and nausea as main side effects.
Market research: 39 of 40 surveyed psychiatrists would prescribe Exxua; strong psychiatrist interest in side effect profile.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Aytu Biopharma earnings date
Q1 202612 Nov, 2025
Next Aytu Biopharma earnings date
Q1 202612 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Aytu Biopharma Inc is a specialty pharmaceutical company focused on developing and commercializing treatments for rare and pediatric-onset disorders. The company’s portfolio includes prescription therapeutics and consumer health products targeting genetic, neurological, and respiratory conditions. It operates through research, licensing, and marketing of branded pharmaceuticals. Aytu Biopharma Inc is headquartered in Englewood, Colorado, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage